Zervou, Fani External Entity

Publications

Sort by

Selected publications

  • Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy.  Blood2015 Academic Article GET IT
    Times cited: 9

Other